All articles tagged with #pediatric medicine
Dr. Jane Burns has spent 40 years investigating the cause of Kawasaki disease, a rare childhood illness that can lead to heart problems. The disease's symptoms can be mistaken for other illnesses, and its cause remains unknown. Dr. Burns leads the research at the University of California San Diego's Kawasaki Disease Research Center and is dedicated to solving this medical mystery.
A study published in JAMA Pediatrics found that ChatGPT had only a 17% accuracy rate when diagnosing pediatric medical cases, highlighting significant limitations in its current ability to replace human pediatricians. The AI struggled with understanding complex medical relationships and provided incorrect or overly broad diagnoses in the majority of the 100 cases tested. Researchers suggest that improvements could be made by training the AI on accurate medical literature and providing it with real-time medical data.
Doctors are warning about the increasing number of pediatric high-powered magnet injuries, which have caused children to be sent to the emergency room and even threatened their lives. The magnets causing these injuries are found in children's toys and some desk or fidget toys. There was a significant increase in injuries in 2008, leading to a recall by the U.S. Consumer Product Safety Commission. However, the recall was overturned, resulting in a rise in injuries again. Doctors are now waiting to see the impact of a recent recall. Education and supervision alone may not be enough to prevent these injuries, as even families who were aware of the dangers reported incidents. Additionally, the conference also highlighted the rise in injuries from e-bikes and scooters, particularly during the back-to-school season.
The FDA has approved Jardiance and Synjardy as new oral therapies to treat pediatric type 2 diabetes in children aged 10 and older. Type 2 diabetes is a chronic and progressive condition that affects the body's ability to use insulin normally, leading to high levels of glucose in the blood. Empagliflozin, the active ingredient in Jardiance and Synjardy, works by increasing the excretion of glucose in the urine. The incidence of type 2 diabetes in children is expected to continue increasing, and these approvals provide much-needed additional treatment options for children with type 2 diabetes.